10.1124/dmd.111.038851
The research investigates the oxidative metabolism of methylisoeugenol, a minor constituent of essential oils and an FDA-approved food additive, using liver microsomes from human, rat, and bovine origins. The study aims to identify and quantify the metabolites formed, particularly focusing on potential reactive intermediates that could have adverse effects. Key chemicals involved in the research include methylisoeugenol itself, various reagents for synthesis and analysis such as acetone, CDCl3, dimethyl sulfoxide (DMSO), and NADPH-regenerating system components like glucose-6-phosphate dehydrogenase. The metabolites identified include 3'-hydroxymethylisoeugenol, isoeugenol, isochavibetol, 6-hydroxymethylisoeugenol, and others, with notable differences in metabolic patterns between species. The study highlights the formation of reactive metabolites such as 3'-oxomethylisoeugenol and 1',2'-dihydroxymethylisoeugenol, suggesting the need for further investigation into their potential toxicological implications.
Xi
